EC looks into antidepressants, hypertension drugs in Watson, Actavis review
The European Commission is seeking information on antidepressants and hypertension drugs, as part of its review of Watson Pharmaceuticals' plans to buy rival Actavis. The Brussels-based regulator is understood to have addressed questions last...To view the full article, register now.
Already a subscriber? Click here to view full article